ARID1A—the AT-rich interacting domain 1A-is frequent mutational target within SWI/SNF complexes in PDA and has been implicated in PDA initiation and development in the genetically engineered mouse models of the disease [15,16,17]. This evidence concerns the gene ARID1A and Patent ductus arteriosus.